Table 1.

Baseline Characteristics of the ARVC Study Cohort

Viable	n=20
Age (y)	44±14
Male	13(65%)
Clinical symptom
Palpitations	17 (85%)
Pre-syncope	7 (35%)
Syncope	1 (5%)
Cardiac arrest	1 (5%)
LVEF	59.1±9.2%
Task force criteria (%)
Structural abnormalities*	13 (65%)/2 (10%)
Depolarization changes*	5 (25%)/15 (75%)
Repolarization changes*	13 (65%)/7 (35%)
Ventricular arrhythmias*	12 (60%)/8 (40%)
Family history*	7(35%)/10(50%)
ICD	20(100%)
Medication at discharge
Drug free or β-blocker only	12 (60%)
Class I or III	8 (40%)

^*According to the 2010 Revised Task Force criteria (Major/minor)